Access cutting-edge chemotherapy-induced thrombocytopenia treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access chemotherapy-induced thrombocytopenia specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chemotherapy-induced thrombocytopenia treatment provided free
To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer, or breast cancer measured by the ability to administer on-time, full-dose chemotherapy
Sponsor: Amgen
Check if you qualify for this chemotherapy-induced thrombocytopenia clinical trial in Chicago, IL
If you're searching for chemotherapy-induced thrombocytopenia treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chemotherapy-induced thrombocytopenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.